What is the optimal treatment of mood and anxiety disorders?

Clinical Psychology: Science and Practice

Volumn 12, Issue 1, 2005, Pages 92-96

  Fava, Giovanni A ^a,b   Ruini, Chiara ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Anxiety disorders; Cognitive behavior therapy; Combination treatment; Mood disorders; Sequential treatment

Indexed keywords

ANTIDEPRESSANT AGENT; CLONAZEPAM; IMIPRAMINE; PAROXETINE; PLACEBO; PSYCHOTROPIC AGENT;

ANXIETY DISORDER; ARTICLE; BEHAVIOR THERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSION; DRUG EFFICACY; FOLLOW UP; HUMAN; MAJOR DEPRESSION; MOOD DISORDER; NONBIOLOGICAL MODEL; PANIC; PSYCHOTHERAPY; RELAPSE; SYMPTOMATOLOGY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 14644415491     PISSN: 09695893     EISSN: None     Source Type: Journal    
DOI: 10.1093/clipsy/bpi011     Document Type: Article

References (36)

1. Ananth, J. (1998). Treatment-resistant depression. Psychotherapy and Psychosomatics, 67, 61-70.
2. Baldessarini, R. J., Ghaemi, S. N., & Viguera, A. C. (2002). Tolerance in antidepressant treatment. Psychotherapy and Psychosomatics, 71, 177-179.
3. Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000). Cognitive behavioural therapy, impramine and their combination for panic disorder. Journal of the American Medical Association, 283 2529-2536.
4. Emmelkamp, P. M. G., Bouman, T. K., & Scholing, A. (1993). Anxiety disorders. Chichester, England: Wiley.
5. Fabbri, S. (2004). Family intervention approach to loss of clinical effect during antidepressant treatment. Psychotherapy and Psychosomatics, 73, 124.
6. Fava, G. A. (1996). The concept of recovery in affective disorders. Psychotherapy and Psychosomatics, 65, 2-13.
7. Fava, G. A. (2003). Can long-term treatment with anti-depressant drugs worsen the course of depression? Journal of Clinical Psychiatry, 64, 123-133.
8. Fava, G. A., Grandi, S., Zielezny, M., Canestrari, R., & Morphy, M. A. (1994). Cognitive behavioral treatment of residual symptoms in primary major depressive disorder. American Journal of Psychiatry, 151, 1295-1299.
9. Fava, G. A., Grandi, S., Zielezny, M., Rafanelli, C., & Canestrari, R. (1996). Four year outcome for cognitive behavioral treatment of residual symptoms in major depression. American Journal of Psychiatry, 153, 945-947.
10. Fava, G. A., & Kellner, R. (1993). Staging. Acta Psychiatrica Scandinavica, 87, 225-230.
11. Fava, G. A., Rafanelli, C., Grandi, S., Canestrari, R., & Morphy, M. A. (1998). Six year outcome for cognitive behavioral treatment of residual symptoms in major depression. American Journal of Psychiatry, 155, 1443-1445.
12. Fava, G. A., Rafanelli, C., Grandi, S., Conti, S., & Belluardo, P. (1998). Prevention of recurrent depression with cognitive behavioral therapy. Archives of General Psychiatry, 55, 816-820.
13. Fava, G. A., & Ruini, C. (2002). The sequential approach to relapse prevention in unipolar depression. World Psychiatry, 1, 10-15.
14. Fava, G. A., & Ruini, C. (2003). Development and characteristics of a well-being enhancing psychotherapeutic strategy: Well-being therapy. Journal of Behavior Therapy and Experimental Psychiatry, 34, 45-63.
15. Fava, G. A., Ruini, C., Rafanelli, C., Finos, L., Conti, S., & Grandi, S. (2004). Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. American Journal of Psychiatry, 161, 1872-1876.
16. Fava, G. A., Ruini, C., Rafanelli, C., Finos, L., Salmaso, L., Mangelli, L., et al. (2005). Well-being therapy of generalized anxiety disorder. Psychotherapy and Psychosomatics, 74, 26-30.
17. Fava, G. A., Ruini, C., Rafanelli, C., & Grandi, S. (2002). Cognitive behavior approach to loss of clinical effect during long-term antidepressant treatment. American Journal of Psychiatry, 159, 2094-2095.
18. Fava, G. A., Ruini, C., & Sonino, N. (2003). Management of recurrent depression in primary care. Psychotherapy and Psychosomatics, 72, 3-9.
19. Fava, G. A., Savron, G., Grandi, S., & Rafanelli, C. (1997). Cognitive-behavioral management of drug-resistant major depression disorder. Journal of Clinical Psychiatry, 58, 278-282.
20. Feinstein, A. R. (1995). Meta analysis: Statistical alchemy for the 21st century. Journal of Clinical Epidemiology, 48, 71-79.
21. Haug, T. T., Blomhoff, S., Hellstrom, K., Holme, I., Humble, M., Madsbur, H. P., et al. (2003). Exposure therapy and sertraline in social phobia. British Journal of Psychiatry, 182, 312-318.
22. Ma, S. H., & Teasdale, J. D. (2004). Mindfulness-based cognitive therapy for depression. Journal of Consulting and Clinical Psychology, 72, 31-40.
23. Marks, I. M., Swinson, R. P., Basoglu, M., Kuch, K., Noshirvani, H., O'Sullivan, G., et al. (1993). Alprazolam and exposure alone and combined in panic disorder with agoraphobia. British Journal of Psychiatry, 162, 776-787.
24. Mavissakalian, M. R., & Perel, J. (1999). Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia. Archives of General Psychiatry, 56, 821-827.
25. Murthy, R. S. (2004). Psychiatric comorbididty presents special challenges in developing countries. World Psychiatry, 3, 28-30.
26. Otto, M. W., Smits, J. A. J., & Reese, H. E. (2005). Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: Review and analysis. Clinical Psychology: Science and Practice, 12, 72-86.
27. Pampallona, S., Bollini, P., Tibaldi, G., Kupelnik, B., & Munizza, C. (2004). Combined pharmacotherapy and psychological treatment for depression. Archives of General Psychiatry, 61, 714-719.
28. Paykel, E. S., Scott, J., Teasdale, J.D.Johnson, A. L., Garland, A., Moore, R., et al. (1999). Prevention of relapse in residual depression by cognitive therapy. Archives of General Psychiatry, 56 829-835.
29. Pincus, H. A., Tew, J. D., & First, M. B. (2004). Psychiatric comorbidity: Is more less? World Psychiatry, 3, 18-23.
30. Pollack, M. H., Otto, M. W., & Rosenbaum, J. F. (Eds.). (1996). Challenges in clinical practice. New York: Guilford.
31. Regier, D. A. (2004). State-of-the-art psychiatric diagnosis. World Psychiatry, 3, 25-26.
32. Reus, V. I., Weingartner, H., & Post, R. M. (1979). Clinical implications of state-dependent learning. American Journal of Psychiatry, 136, 927-931.
33. Scholing, A., & Emmelkamp, P. M. G. (1993). Cognitive and behavioral treatments of fear of blushing, sweating or trembling. Behaviour Research and Therapy, 31, 155-170.
34. Stewart, J. W., Mercier, M. A., Agosti, V., Guardino, M., & Quitkin, F. M. (1993). Imipramine is effective after unsuccessful cognitive therapy. Journal of Clinical Psychopharmacology, 13, 114-119.
35. Teasdale, J. D., Segal, Z. V., Williams, J. M. G., Ridgeway, V. A., Soulsby, J. M., & Lan, M. A. (2000). Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Journal of Consulting and Clinical Psychology, 68, 615-623.
36. Toni, C., Perugi, G., Frare, F., Mata, B., & Akiskal, H. S. (2004). Spontaneous treatment discontinuation in panic disorder patients treated with antidepressants. Acta Psychiatrica Scandinavica, 110, 130-137.